The European Medicines Agency has concluded that unusual blood clots with low blood platelets should be listed as very rare side effects of the Oxford University/AstraZeneca Covid-19 vaccine. But overall, the vaccine’s benefits outweigh its risks. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
